Research Spotlight: A Clinical Trial for Epileptic Encephalopathy with Continuous Spike-and-Wave during Sleep

Neurocrine Biosciences is looking for children 4 to 12 years old with a clinical diagnosis of EECSWS to take part in the Steamboat Study, a 21-week clinical research study. The primary purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication for EECSWS. To learn more, visit SteamboatEpilepsy.com.